GEHC – GE HealthCare Technologies Inc

GEHC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.1

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

-1.24

EPS Last/This Y

0.36

EPS This/Next Y

0.48

Price

71.77

Target Price

82.18

Analyst Recom

1.62

Performance Q

Upside

33.3%

Beta

0.82

Ticker: GEHC

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	GEHC	65.3	0.57	0.88	63241
2026-07-14	GEHC	61.66	0.57	0.49	63666
2026-07-15	GEHC	63.2	0.56	0.77	68186
2026-07-16	GEHC	65.7	0.57	0.30	69365
2026-07-17	GEHC	63.05	0.57	0.51	69673
2026-07-20	GEHC	62.83	0.56	0.66	59571
2026-07-21	GEHC	62.04	0.57	0.95	63748
2026-07-22	GEHC	61.4	0.58	0.97	64683
2026-07-23	GEHC	61.99	0.58	0.30	65293
2026-07-24	GEHC	60.59	0.58	0.79	66140
2026-07-27	GEHC	61.12	0.57	0.35	66683
2026-07-28	GEHC	64.22	0.57	0.12	68507
2026-07-29	GEHC	71.93	0.48	0.27	82631
2026-07-30	GEHC	69.94	0.49	0.72	86240
2026-07-31	GEHC	68.03	0.49	0.35	87555
2026-08-03	GEHC	69.72	0.57	0.36	72574
2026-08-04	GEHC	70.25	0.56	0.41	76403
2026-08-05	GEHC	70.22	0.55	0.73	78297
2026-08-06	GEHC	70.34	0.55	1.00	79390
2026-08-07	GEHC	71.77	0.56	0.26	80961
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	GEHC	65.31	-2.4	237.4	4.87
2026-07-14	GEHC	61.73	-2.4	76.0	4.87
2026-07-15	GEHC	63.22	-2.4	276.6	4.87
2026-07-16	GEHC	65.69	-2.4	312.6	4.87
2026-07-17	GEHC	63.06	-2.5	112.9	4.87
2026-07-20	GEHC	62.83	-2.5	204.5	4.87
2026-07-21	GEHC	62.04	-2.5	182.8	4.87
2026-07-22	GEHC	61.41	-2.5	188.7	4.87
2026-07-23	GEHC	61.99	-2.5	237.4	4.87
2026-07-24	GEHC	60.56	-2.5	156.5	4.87
2026-07-27	GEHC	61.08	-2.5	234.4	4.87
2026-07-28	GEHC	64.21	-2.3	339.3	4.87
2026-07-29	GEHC	71.93	-2.3	519.9	4.87
2026-07-30	GEHC	69.94	-2.3	63.5	4.87
2026-07-31	GEHC	68.04	12.8	63.7	4.92
2026-08-03	GEHC	69.72	12.8	291.9	4.92
2026-08-04	GEHC	69.72	12.8	291.9	4.92
2026-08-05	GEHC	70.24	12.6	226.2	4.92
2026-08-06	GEHC	70.32	12.6	230.1	4.92
2026-08-07	GEHC	71.77	12.6	281.4	4.92
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	GEHC	8.22	-2.63	3.17
2026-07-14	GEHC	8.22	-2.63	3.17
2026-07-15	GEHC	8.22	-2.63	3.17
2026-07-16	GEHC	8.22	-2.63	3.17
2026-07-17	GEHC	8.22	-2.63	3.17
2026-07-20	GEHC	8.22	-1.88	3.17
2026-07-21	GEHC	8.22	-1.88	3.17
2026-07-22	GEHC	8.22	-1.88	3.17
2026-07-23	GEHC	8.22	-1.88	3.17
2026-07-24	GEHC	8.22	-1.88	3.17
2026-07-27	GEHC	8.22	-3.12	4.07
2026-07-28	GEHC	8.22	-3.12	4.07
2026-07-29	GEHC	8.22	-3.12	4.07
2026-07-30	GEHC	8.22	-3.12	4.07
2026-07-31	GEHC	8.22	-3.12	4.07
2026-08-03	GEHC	8.28	-3.64	4.10
2026-08-04	GEHC	8.28	-3.64	4.10
2026-08-05	GEHC	8.28	-3.64	4.10
2026-08-06	GEHC	8.28	-3.64	4.10
2026-08-07	GEHC	8.28	-3.64	4.10
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

2.84

Avg. EPS Est. Current Quarter

1.2

Avg. EPS Est. Next Quarter

1.6

Insider Transactions

8.28

Institutional Transactions

-3.64

Beta

0.82

Average Sales Estimate Current Quarter

5350

Average Sales Estimate Next Quarter

5940

Fair Value

78.56

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

24.3

Max Drawdown 5-Year %

Target Price

82.18

P/E

16.49

Forward P/E

13.2

PEG

1.38

P/S

1.52

P/B

2.95

P/Free Cash Flow

20.53

EPS

4.35

Average EPS Est. Cur. Y

4.92

EPS Next Y. (Est.)

5.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.33

Relative Volume

0.52

Return on Equity vs Sector %

-9.2

Return on Equity vs Industry %

6.6

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.05

EBIT Estimation

281.4

◆ GEHC Healthcare

$71.77

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

8/25

Volume

8/15

Valuation

16/20

TP/AR

2/10

Options

6/10

RSI

64.7

Range 1M

95%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

15/30

Estimates

8/20

Inst/Vol

3/15

Options

9/10

EPS Yr

7.3%

EPS NY

10.4%

52W%

40.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +38.5% upside

Quality

11/30

Valuation

14/30

Growth

11/25

Stability

5/10

LT Trend

2/5

Upside

+38.5%

Quality

MoS

GEHC — P/E HistoricalMedical Devices

GE HealthCare Technologies Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 54000

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GEHC

Latest News

—

Caricamento notizie per GEHC…

stock quote shares GEHC – GE HealthCare Technologies Inc Stock Price stock today

news today GEHC – GE HealthCare Technologies Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch GEHC – GE HealthCare Technologies Inc yahoo finance google finance

stock history GEHC – GE HealthCare Technologies Inc invest stock market

stock prices GEHC premarket after hours

ticker GEHC fair value insiders trading

QDEL – QuidelOrtho Corporation

QDEL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

17.52

Margin Of Safety %

Put/Call OI Ratio

1.3

EPS Next Q Diff

-4.12

EPS Last/This Y

18.53

EPS This/Next Y

0.55

Price

12.29

Target Price

21.33

Analyst Recom

2.5

Performance Q

14.07

Upside

-4,492.1%

Beta

0.69

Ticker: QDEL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	QDEL	17.88	1.43	0.86	15894
2026-07-14	QDEL	17.67	1.43	3.14	15949
2026-07-15	QDEL	18.21	1.43	0.01	15972
2026-07-16	QDEL	18.24	1.43	2.87	16014
2026-07-17	QDEL	17.37	1.42	999.99	16039
2026-07-20	QDEL	16.57	2.34	0.38	11821
2026-07-21	QDEL	16.45	2.34	2.31	11876
2026-07-22	QDEL	16.7	2.34	0.00	11908
2026-07-23	QDEL	16.57	2.33	0.05	11922
2026-07-24	QDEL	16.06	2.33	0.02	11926
2026-07-27	QDEL	16.83	2.30	0.00	11967
2026-07-28	QDEL	16.67	2.30	1.60	11972
2026-07-29	QDEL	16.49	2.30	4.33	11980
2026-07-30	QDEL	16.55	2.30	0.00	11991
2026-07-31	QDEL	16.78	2.30	2.40	11992
2026-08-03	QDEL	17.71	2.30	0.48	11979
2026-08-04	QDEL	17.59	2.29	0.73	12001
2026-08-05	QDEL	17.49	2.28	0.31	12016
2026-08-06	QDEL	16.36	2.25	0.02	12057
2026-08-07	QDEL	12.3	1.30	1.34	14768
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	QDEL	17.90	-100.0	-	1.86
2026-07-14	QDEL	17.68	-100.0	-	1.86
2026-07-15	QDEL	18.22	-100.0	-	1.86
2026-07-16	QDEL	18.23	-100.0	-	1.86
2026-07-17	QDEL	17.38	-100.0	-	1.86
2026-07-20	QDEL	16.56	-100.0	-	1.86
2026-07-21	QDEL	16.45	-100.0	-	1.86
2026-07-22	QDEL	16.68	-100.0	-	1.86
2026-07-23	QDEL	16.58	-100.0	-	1.86
2026-07-24	QDEL	16.04	-100.0	-	1.86
2026-07-27	QDEL	16.82	-100.0	-	1.86
2026-07-28	QDEL	16.67	-100.0	-	1.86
2026-07-29	QDEL	16.50	-100.0	-	1.86
2026-07-30	QDEL	16.58	-100.0	-	1.86
2026-07-31	QDEL	16.76	-100.0	-	1.86
2026-08-03	QDEL	17.72	-100.0	-	1.84
2026-08-04	QDEL	17.72	-100.0	-	1.84
2026-08-05	QDEL	17.49	-100.0	-	1.84
2026-08-06	QDEL	16.33	-100.0	-	1.84
2026-08-07	QDEL	12.29	-100.0	-	1.84
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	QDEL	3.06	-1.59	17.08
2026-07-14	QDEL	3.06	-1.59	17.08
2026-07-15	QDEL	3.06	-1.59	17.08
2026-07-16	QDEL	3.06	-1.59	17.08
2026-07-17	QDEL	3.06	-1.59	17.08
2026-07-20	QDEL	3.06	-1.64	17.08
2026-07-21	QDEL	3.06	-1.64	17.08
2026-07-22	QDEL	3.06	-1.64	17.08
2026-07-23	QDEL	3.06	-1.64	17.08
2026-07-24	QDEL	3.06	-1.64	17.08
2026-07-27	QDEL	3.06	-1.60	17.52
2026-07-28	QDEL	3.06	-1.60	17.52
2026-07-29	QDEL	3.06	-1.60	17.52
2026-07-30	QDEL	3.06	-1.60	17.52
2026-07-31	QDEL	3.06	-1.60	17.52
2026-08-03	QDEL	3.06	-2.27	17.52
2026-08-04	QDEL	3.06	-2.27	17.52
2026-08-05	QDEL	3.06	-2.27	17.52
2026-08-06	QDEL	3.06	-2.27	17.52
2026-08-07	QDEL	3.06	-2.27	17.52
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

4.97

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

0.85

Insider Transactions

3.06

Institutional Transactions

-2.27

Beta

0.69

Average Sales Estimate Current Quarter

624

Average Sales Estimate Next Quarter

715

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.2

Max Drawdown 5-Year %

-94.3

Target Price

21.33

P/E

Forward P/E

5.14

PEG

0.47

P/S

0.31

P/B

0.45

P/Free Cash Flow

EPS

-15.41

Average EPS Est. Cur. Y

1.84

EPS Next Y. (Est.)

2.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-39.2

Relative Volume

2.91

Return on Equity vs Sector %

-92.7

Return on Equity vs Industry %

-76.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.08

EBIT Estimation

◆ QDEL Healthcare

$12.28

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

11/25

Volume

0/15

Valuation

15/20

TP/AR

1/10

Options

1/10

RSI

29.1

Range 1M

12.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

15/30

Estimates

0/20

Inst/Vol

5/15

Options

2/10

EPS Yr

-13.2%

EPS NY

29.8%

52W%

9.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +436.2% upside

Quality

4/30

Valuation

21/30

Growth

11/25

Stability

3/10

LT Trend

4/5

Upside

+436.2%

Quality

QDEL — P/E HistoricalDiagnostics & Research

QuidelOrtho Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 6500

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

QDEL

Latest News

—

Caricamento notizie per QDEL…

stock quote shares QDEL – QuidelOrtho Corporation Stock Price stock today

news today QDEL – QuidelOrtho Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch QDEL – QuidelOrtho Corporation yahoo finance google finance

stock history QDEL – QuidelOrtho Corporation invest stock market

stock prices QDEL premarket after hours

ticker QDEL fair value insiders trading

INGN – Inogen Inc.

INGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.03

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.3

EPS Last/This Y

0.49

EPS This/Next Y

0.11

Price

6.06

Target Price

12.67

Analyst Recom

Performance Q

-15.86

Upside

-620.7%

Beta

1.6

Ticker: INGN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	INGN	6.53	0.11	999.99	504
2026-07-14	INGN	6.34	0.11	999.99	504
2026-07-15	INGN	6.37	0.31	999.99	598
2026-07-16	INGN	6.68	0.32	999.99	600
2026-07-17	INGN	6.58	0.32	999.99	600
2026-07-20	INGN	6.41	0.33	0.00	577
2026-07-21	INGN	6.41	0.31	0.00	612
2026-07-22	INGN	6.51	0.31	0.00	613
2026-07-23	INGN	6.33	0.21	0.00	840
2026-07-24	INGN	6.14	0.17	0.00	977
2026-07-27	INGN	6.3	0.17	0.00	977
2026-07-28	INGN	6.43	0.17	0.00	1007
2026-07-29	INGN	6.44	0.17	0.00	1007
2026-07-30	INGN	6.41	0.15	0.53	1093
2026-07-31	INGN	6.45	0.17	0.00	1203
2026-08-03	INGN	6.7	0.17	1.67	1202
2026-08-04	INGN	6.93	0.18	0.00	1219
2026-08-05	INGN	6.54	0.18	0.00	1235
2026-08-06	INGN	6.45	0.17	0.00	1254
2026-08-07	INGN	6.05	0.17	0.00	1285
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	INGN	6.53	-100.0	-	-0.37
2026-07-14	INGN	6.34	-100.0	-	-0.37
2026-07-15	INGN	6.39	-100.0	-	-0.37
2026-07-16	INGN	6.68	-100.0	-	-0.37
2026-07-17	INGN	6.57	-100.0	-	-0.37
2026-07-20	INGN	6.39	-100.0	-	-0.37
2026-07-21	INGN	6.43	-100.0	-	-0.37
2026-07-22	INGN	6.50	-100.0	-	-0.37
2026-07-23	INGN	6.32	-100.0	-	-0.37
2026-07-24	INGN	6.14	-100.0	-	-0.37
2026-07-27	INGN	6.30	-100.0	-	-0.37
2026-07-28	INGN	6.43	-100.0	-	-0.37
2026-07-29	INGN	6.44	-100.0	-	-0.37
2026-07-30	INGN	6.41	-100.0	-	-0.37
2026-07-31	INGN	6.43	-100.0	-	-0.37
2026-08-03	INGN	6.70	-100.0	-	-0.37
2026-08-04	INGN	6.70	-100.0	-	-0.37
2026-08-05	INGN	6.54	-100.0	-	-0.37
2026-08-06	INGN	6.47	-100.0	-	-0.37
2026-08-07	INGN	6.06	-100.0	-	-0.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	INGN	-2.20	0.16	3.93
2026-07-14	INGN	-2.20	0.16	3.93
2026-07-15	INGN	-2.20	0.16	3.93
2026-07-16	INGN	-2.20	0.16	3.93
2026-07-17	INGN	-2.20	0.16	3.93
2026-07-20	INGN	-2.20	0.46	3.93
2026-07-21	INGN	-2.20	0.46	3.93
2026-07-22	INGN	-2.20	0.46	3.93
2026-07-23	INGN	-2.20	0.46	3.93
2026-07-24	INGN	-2.20	0.46	3.93
2026-07-27	INGN	-2.19	0.46	4.03
2026-07-28	INGN	-2.19	0.46	4.03
2026-07-29	INGN	-2.19	0.46	4.03
2026-07-30	INGN	-2.19	0.46	4.03
2026-07-31	INGN	-2.19	0.46	4.03
2026-08-03	INGN	-2.19	-0.90	4.03
2026-08-04	INGN	-2.19	-0.90	4.03
2026-08-05	INGN	-2.19	-0.90	4.03
2026-08-06	INGN	-2.19	-0.90	4.03
2026-08-07	INGN	-2.19	-0.90	4.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.3

Avg. EPS Est. Current Quarter

-0.06

Avg. EPS Est. Next Quarter

Insider Transactions

-2.19

Institutional Transactions

-0.9

Beta

1.6

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.8

Max Drawdown 5-Year %

-93.5

Target Price

12.67

P/E

Forward P/E

PEG

P/S

0.46

P/B

0.91

P/Free Cash Flow

EPS

-0.9

Average EPS Est. Cur. Y

-0.37

EPS Next Y. (Est.)

-0.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.94

Relative Volume

1.96

Return on Equity vs Sector %

-40.9

Return on Equity vs Industry %

-25.1

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.15

EBIT Estimation

◆ INGN Healthcare

$6.05

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

12/25

Volume

3/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

39.4

Range 1M

32.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

17/30

Estimates

0/20

Inst/Vol

4/15

Options

8/10

EPS Yr

12%

EPS NY

37%

52W%

19.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +109.4% upside

Quality

6/30

Valuation

16/30

Growth

13/25

Stability

7/10

LT Trend

4/5

Upside

+109.4%

Quality

INGN — P/E HistoricalMedical Devices

Inogen, Inc

Sector: Healthcare

Industry: Medical Devices

Employees: 753

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

INGN

Latest News

—

Caricamento notizie per INGN…

stock quote shares INGN – Inogen Inc. Stock Price stock today

news today INGN – Inogen Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch INGN – Inogen Inc. yahoo finance google finance

stock history INGN – Inogen Inc. invest stock market

stock prices INGN premarket after hours

ticker INGN fair value insiders trading

XAIR – Beyond Air Inc

XAIR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.3

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

39.6

EPS This/Next Y

15.6

Price

5.48

Target Price

190

Analyst Recom

1.67

Performance Q

-46.1

Upside

-21,482.1%

Beta

0.17

Ticker: XAIR

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	XAIR	7.43	N/A	N/A	0
2026-07-14	XAIR	5.86	N/A	N/A	0
2026-07-15	XAIR	5.59	N/A	N/A	0
2026-07-16	XAIR	5.45	N/A	N/A	0
2026-07-17	XAIR	5.705	N/A	N/A	0
2026-07-20	XAIR	5.9	N/A	N/A	0
2026-07-21	XAIR	5.86	N/A	N/A	0
2026-07-22	XAIR	5.83	N/A	N/A	0
2026-07-23	XAIR	5.4	N/A	N/A	0
2026-07-24	XAIR	5.2	N/A	N/A	0
2026-07-27	XAIR	5.37	N/A	N/A	0
2026-07-28	XAIR	5.53	N/A	N/A	0
2026-07-29	XAIR	5.5	N/A	N/A	0
2026-07-30	XAIR	5.37	N/A	N/A	0
2026-07-31	XAIR	5.34	N/A	N/A	0
2026-08-03	XAIR	6.33	N/A	N/A	0
2026-08-04	XAIR	6.21	N/A	N/A	0
2026-08-05	XAIR	5.69	N/A	N/A	0
2026-08-07	XAIR	5.63	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	XAIR	7.41	-	-	-2.03
2026-07-14	XAIR	5.82	-	-	-2.03
2026-07-15	XAIR	5.61	-	-	-2.03
2026-07-16	XAIR	5.55	-	-	-2.03
2026-07-17	XAIR	5.55	-	-	-40.60
2026-07-20	XAIR	5.90	-	-	-40.60
2026-07-21	XAIR	5.93	-	-	-40.60
2026-07-22	XAIR	5.85	-	-	-40.60
2026-07-23	XAIR	5.53	-	-	-40.60
2026-07-24	XAIR	5.20	-	-	-40.60
2026-07-27	XAIR	5.16	-	-	-40.60
2026-07-28	XAIR	5.58	-	-	-40.60
2026-07-29	XAIR	5.50	-	-	-40.60
2026-07-30	XAIR	5.54	-	-	-40.60
2026-07-31	XAIR	5.30	-	-	-40.60
2026-08-03	XAIR	6.33	-	-	-40.60
2026-08-04	XAIR	6.33	-	-	-40.60
2026-08-05	XAIR	5.66	-	-	-40.60
2026-08-06	XAIR	5.66	-	-	-40.60
2026-08-07	XAIR	5.48	-	-	-40.60
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	XAIR	0.00	-0.90	2.36
2026-07-14	XAIR	0.00	-0.90	2.36
2026-07-15	XAIR	0.00	-0.90	2.37
2026-07-16	XAIR	0.00	-0.90	2.34
2026-07-17	XAIR	0.00	-0.90	2.34
2026-07-20	XAIR	0.00	0	2.34
2026-07-21	XAIR	0.00	0	2.55
2026-07-22	XAIR	0.00	0	2.55
2026-07-23	XAIR	0.00	0	2.55
2026-07-24	XAIR	0.00	0	2.55
2026-07-27	XAIR	0.00	0	3.30
2026-07-28	XAIR	0.00	0	3.30
2026-07-29	XAIR	0.00	0	3.30
2026-07-30	XAIR	0.00	0	3.30
2026-07-31	XAIR	0.00	0	3.30
2026-08-03	XAIR	124.72	0	3.30
2026-08-04	XAIR	124.72	0	3.30
2026-08-05	XAIR	124.72	0	3.30
2026-08-06	XAIR	124.85	0	3.30
2026-08-07	XAIR	124.65	0	3.30
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-10.8

Avg. EPS Est. Next Quarter

-10.2

Insider Transactions

124.65

Institutional Transactions

Beta

0.17

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

190

P/E

Forward P/E

PEG

P/S

0.5

P/B

0.52

P/Free Cash Flow

EPS

-88.16

Average EPS Est. Cur. Y

-40.6

EPS Next Y. (Est.)

-25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-432.99

Relative Volume

0.53

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ XAIR Healthcare

$5.36

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

15/25

Volume

11/15

Valuation

12/20

TP/AR

5/10

Options

0/10

RSI

37.1

Range 1M

14.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

10/30

Estimates

7/20

Inst/Vol

0/15

Options

0/10

EPS Yr

EPS NY

52W%

0.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +3444.8% upside

Quality

2/30

Valuation

16/30

Growth

7/25

Stability

3/10

LT Trend

1/5

Upside

+3444.8%

Quality

XAIR — P/E HistoricalMedical Devices

Beyond Air, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 54

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

XAIR

Latest News

—

Caricamento notizie per XAIR…

stock quote shares XAIR – Beyond Air Inc Stock Price stock today

news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch XAIR – Beyond Air Inc yahoo finance google finance

stock history XAIR – Beyond Air Inc invest stock market

stock prices XAIR premarket after hours

ticker XAIR fair value insiders trading

OPGN – Opgen Inc

OPGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.02

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

24.75

Target Price

Analyst Recom

Performance Q

-57.39

Upside

N/A

Beta

-0.64

Ticker: OPGN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	OPGN	24.75	N/A	N/A	0
2026-07-14	OPGN	24.75	N/A	N/A	0
2026-07-15	OPGN	24.75	N/A	N/A	0
2026-07-16	OPGN	24.75	N/A	N/A	0
2026-07-17	OPGN	24.75	N/A	N/A	0
2026-07-20	OPGN	24.75	N/A	N/A	0
2026-07-21	OPGN	24.75	N/A	N/A	0
2026-07-22	OPGN	24.75	N/A	N/A	0
2026-07-23	OPGN	24.75	N/A	N/A	0
2026-07-24	OPGN	24.75	N/A	N/A	0
2026-07-27	OPGN	24.75	N/A	N/A	0
2026-07-28	OPGN	24.75	N/A	N/A	0
2026-07-29	OPGN	24.75	N/A	N/A	0
2026-07-30	OPGN	24.75	N/A	N/A	0
2026-07-31	OPGN	24.75	N/A	N/A	0
2026-08-03	OPGN	24.75	N/A	N/A	0
2026-08-04	OPGN	24.75	N/A	N/A	0
2026-08-05	OPGN	24.75	N/A	N/A	0
2026-08-07	OPGN	24.75	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

-0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

27.2

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

6.13

P/B

P/Free Cash Flow

EPS

-40.32

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

54.6

Return on Equity vs Industry %

52.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for OPGN

OPGN — P/E HistoricalDiagnostics & Research

OPGN

Latest News

—

Caricamento notizie per OPGN…

stock quote shares OPGN – Opgen Inc Stock Price stock today

news today OPGN – Opgen Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch OPGN – Opgen Inc yahoo finance google finance

stock history OPGN – Opgen Inc invest stock market

stock prices OPGN premarket after hours

ticker OPGN fair value insiders trading

OFIX – Orthofix Medical Inc

OFIX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.28

Margin Of Safety %

Put/Call OI Ratio

1.64

EPS Next Q Diff

0.74

EPS Last/This Y

2.6

EPS This/Next Y

0.57

Price

10.27

Target Price

14.25

Analyst Recom

1.8

Performance Q

-14.83

Upside

-620.9%

Beta

0.66

Ticker: OFIX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	OFIX	11.79	1.67	999.99	352
2026-07-14	OFIX	10.95	1.71	999.99	358
2026-07-15	OFIX	11.29	1.73	0.00	360
2026-07-16	OFIX	11.89	1.50	0.20	380
2026-07-17	OFIX	11.6	1.42	999.99	392
2026-07-20	OFIX	11.56	1.42	999.99	392
2026-07-21	OFIX	11.64	1.90	0.00	281
2026-07-22	OFIX	11	1.88	999.99	282
2026-07-23	OFIX	10.97	1.90	0.00	284
2026-07-24	OFIX	11.25	1.88	6.00	285
2026-07-27	OFIX	11.88	1.96	0.50	290
2026-07-28	OFIX	12.27	1.92	0.00	295
2026-07-29	OFIX	12.15	1.92	0.00	295
2026-07-30	OFIX	11.79	1.92	0.00	295
2026-07-31	OFIX	11.79	1.92	0.00	295
2026-08-03	OFIX	12.26	2.06	0.00	288
2026-08-04	OFIX	12.22	2.06	0.00	288
2026-08-05	OFIX	10.35	2.00	0.06	291
2026-08-07	OFIX	10.28	1.64	6.23	325
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	OFIX	11.80	-100.0	-	0.30
2026-07-14	OFIX	10.95	-100.0	-	0.30
2026-07-15	OFIX	11.29	-100.0	-	0.30
2026-07-16	OFIX	11.89	-100.0	-	0.30
2026-07-17	OFIX	11.60	-100.0	-	0.30
2026-07-20	OFIX	11.56	-100.0	-	0.30
2026-07-21	OFIX	11.64	-100.0	-	0.30
2026-07-22	OFIX	11.02	-100.0	-	0.30
2026-07-23	OFIX	10.97	-100.0	-	0.30
2026-07-24	OFIX	11.24	-100.0	-	0.27
2026-07-27	OFIX	11.88	-100.0	-	0.27
2026-07-28	OFIX	12.27	-100.0	-	0.27
2026-07-29	OFIX	12.18	-100.0	-	0.27
2026-07-30	OFIX	11.79	-100.0	-	0.27
2026-07-31	OFIX	11.81	-100.0	-	0.27
2026-08-03	OFIX	12.26	-100.0	-	0.27
2026-08-04	OFIX	12.26	-100.0	-	0.27
2026-08-05	OFIX	10.41	-100.0	-	0.27
2026-08-06	OFIX	10.61	-100.0	-	0.27
2026-08-07	OFIX	10.27	-59.5	-	0.27
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	OFIX	145.72	0.27	5.91
2026-07-14	OFIX	174.64	0.27	5.91
2026-07-15	OFIX	174.63	0.27	5.91
2026-07-16	OFIX	174.63	0.27	5.91
2026-07-17	OFIX	174.63	0.27	5.91
2026-07-20	OFIX	174.64	0.56	5.91
2026-07-21	OFIX	174.64	0.56	5.91
2026-07-22	OFIX	183.00	0.56	5.91
2026-07-23	OFIX	183.00	0.56	5.91
2026-07-24	OFIX	182.99	0.56	5.91
2026-07-27	OFIX	183.00	0.41	6.28
2026-07-28	OFIX	183.00	0.41	6.28
2026-07-29	OFIX	183.00	0.41	6.28
2026-07-30	OFIX	183.00	0.41	6.28
2026-07-31	OFIX	183.00	0.41	6.28
2026-08-03	OFIX	182.99	0.40	6.28
2026-08-04	OFIX	182.99	0.40	6.28
2026-08-05	OFIX	183.00	0.40	6.28
2026-08-06	OFIX	183.00	0.40	6.28
2026-08-07	OFIX	183.00	0.40	6.28
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.39

Avg. EPS Est. Current Quarter

0.08

Avg. EPS Est. Next Quarter

0.35

Insider Transactions

183

Institutional Transactions

0.4

Beta

0.66

Average Sales Estimate Current Quarter

211

Average Sales Estimate Next Quarter

226

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

76.3

Max Drawdown 5-Year %

-79.1

Target Price

14.25

P/E

Forward P/E

PEG

P/S

0.5

P/B

0.98

P/Free Cash Flow

EPS

-1.53

Average EPS Est. Cur. Y

0.27

EPS Next Y. (Est.)

0.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-7.41

Relative Volume

1.41

Return on Equity vs Sector %

-41.7

Return on Equity vs Industry %

-25.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.08

EBIT Estimation

◆ OFIX Healthcare

$10.28

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

22/25

Volume

3/15

Valuation

12/20

TP/AR

1/10

Options

3/10

RSI

Range 1M

11.5%

Sup Dist

0.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

17/30

Estimates

3/20

Inst/Vol

4/15

Options

1/10

EPS Yr

52%

EPS NY

24.6%

52W%

19%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +143.9% upside

Quality

6/30

Valuation

18/30

Growth

13/25

Stability

7/10

LT Trend

4/5

Upside

+143.9%

Quality

OFIX — P/E HistoricalMedical Devices

Orthofix Medical Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 1605

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

OFIX

Latest News

—

Caricamento notizie per OFIX…

stock quote shares OFIX – Orthofix Medical Inc Stock Price stock today

news today OFIX – Orthofix Medical Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch OFIX – Orthofix Medical Inc yahoo finance google finance

stock history OFIX – Orthofix Medical Inc invest stock market

stock prices OFIX premarket after hours

ticker OFIX fair value insiders trading

No more stocks to show

GEHC – GE HealthCare Technologies Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GEHC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

QDEL – QuidelOrtho Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: QDEL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y